picolorlock gold phosphate detection kit (SYGNIS AG)
90
Structured Review
SYGNIS AG
picolorlock gold phosphate detection kit
Picolorlock Gold Phosphate Detection Kit, supplied by SYGNIS AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/picolorlock+gold+phosphate+detection+kit/picolorlock+gold+phosphate+detection+system/pm39121859-605-10-17
Average 90 stars, based on 1 article reviews
Picolorlock Gold Phosphate Detection Kit, supplied by SYGNIS AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/picolorlock+gold+phosphate+detection+kit/picolorlock+gold+phosphate+detection+system/pm39121859-605-10-17
Average 90 stars, based on 1 article reviews
picolorlock gold phosphate detection kit - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Binding and/or hydrolysis of purine-based nucleotides is not required for IM30 ring formation. Article Snippet: Finally, 20 μL of Activity Assay:Article Title: Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1. Article Snippet: The mitochondrial pool of Hsp90 and its mitochondrial paralogue, TRAP1, suppresses cell death and reprograms energy metabolism in cancer cells; therefore, Hsp90 and TRAP1 have been suggested as target proteins for anticancer drug development.. Here, we report that the actual target protein in cancer cell mitochondria is TRAP1, and current Hsp90 inhibitors cannot effectively inactivate TRAP1 because of their insufficient accumulation in the mitochondria.. To develop mitochondrial TRAP1 inhibitors, we determined the crystal structures of human TRAP1 complexed with Hsp90 inhibitors. Article Title: Dual Binding to Orthosteric and Allosteric Sites Enhances the Anticancer Activity of a TRAP1-Targeting Drug. Article Snippet: Subscriber access provided by University of Texas Libraries is published by the American Chemical Society.. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society.. Copyright © American Chemical Society. Article Title: Development of pyrazolo[3,4-d]pyrimidine-6-amine-based TRAP1 inhibitors that demonstrate in vivo anticancer activity in mouse xenograft models. Article Snippet: TNF Receptor Associated Protein 1 (TRAP1) is a mitochondrial paralog of Hsp90 related to the promotion of tumorigenesis in various cancers via maintaining mitochondrial integrity, reducing the production of reactive oxygen species, and reprogramming cellular metabolism.. Consequently, Hsp90 and TRAP1 have been targeted to develop cancer therapeutics.. Herein, we report a series of pyrazolo[3,4-d]pyrimidine derivatives that are mitochondria-permeable TRAP1 inhibitors. Clinical Proteomics:Article Title: Antisense oligonucleotides enhance SLC20A2 expression and suppress brain calcification in a humanized mouse model. Article Snippet: In brief Zhao et al. discover that mRNA and protein expression of phosphate importer SLC20A2 is compromised by intronic mutations, which resulted in increased cryptic-exon incorporation.. Spliceswitching ASOs targeting cryptic exons restore SLC20A2 expression and brain phosphate homeostasis and suppress brain calcification, providing a therapeutic strategy for PFBC patients with SLC20A2 haploinsufficiency. Spectrophotometry:Article Title: Antisense oligonucleotides enhance SLC20A2 expression and suppress brain calcification in a humanized mouse model. Article Snippet: In brief Zhao et al. discover that mRNA and protein expression of phosphate importer SLC20A2 is compromised by intronic mutations, which resulted in increased cryptic-exon incorporation.. Spliceswitching ASOs targeting cryptic exons restore SLC20A2 expression and brain phosphate homeostasis and suppress brain calcification, providing a therapeutic strategy for PFBC patients with SLC20A2 haploinsufficiency. |
